
James E. Akers, PhD, technical consultant, Shibuya Corporation, shares how to advancing aseptic precision.
As global health standards and expectations around sanitary manufacturing increase, advancements in aseptic filling remain a top priority for modern pharmaceutical filling lines. Recent years have seen the pharmaceutical industry shift further toward biologics, high-potency compounds, cell-based therapies, and more complex combination products. As a result, the demands placed on aseptic filling lines are increasing rapidly, and regulatory frameworks such as EU GMP Annex 1,…